<DOC>
	<DOC>NCT01673399</DOC>
	<brief_summary>In this study the investigators compare the usual way of embryo transfer (without medication) with an embryo transfer while administering oxytocine antagonist. This to improve implantation and increase the pregnancy rate.</brief_summary>
	<brief_title>Oxytocin Antagonist in Patients With Repeated Failure of Implantation</brief_title>
	<detailed_description />
	<mesh_term>Atosiban</mesh_term>
	<mesh_term>Vasotocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>IVF/ ICSI patients below 38 years 2e to 6e IVFcycle patients with endocrinological diseases or problems</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>repeated implantation failure (RIF)</keyword>
	<keyword>atosiban</keyword>
	<keyword>pregnancy</keyword>
</DOC>